PASADENA, Calif., Nov. 17, 2013 /PRNewswire/ -- Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for three students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition for high school students. Eric Chen of San Diego, Calif. earned the top individual honors and a $3,000 scholarship for discovering potent influenza endonuclease inhibitors, which could be used to develop anti-flu drugs. Andrew Jin of San Jose, Calif. and Steven Wang of Los Altos, Calif. earned top team honors and a $6,000 scholarship for their research on synergistic chemotherapy drug combinations, which could enhance cancer treatment. The students presented their research this weekend to a panel of judges from the California Institute of Technology (Caltech), host of the Region One Finals. They are now invited to present their work on a national stage at the National Finals in Washington, D.C., December 7-10, 2013, where $500,000 in scholarships will be awarded, including two top prizes of $100,000. The Siemens Competition, a signature program of the Siemens Foundation, is administered by the College Board. "Congratulations to the winners of the Siemens Competition Regional Finals for their remarkable research in STEM," said Jeniffer Harper-Taylor, president of the Siemens Foundation. "I commend these scholars for their innovative and creative projects and look forward to seeing them contend for the top prizes at the National Finals next month." The Winning Individual Eric Chen, a senior at Canyon Crest Academy in San Diego, Calif., won the individual category and a $3,000 college scholarship for his project titled , Discovery of Novel Influenza Endonuclease Inhibitors to Fight Flu Pandemic. For his project, Eric combined computer modeling with experimental research to discover influenza virus inhibitors. These findings could be used to develop new anti-flu drugs that will help protect people against future pandemic outbreaks.